Effects of adenosine A 1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats

European Journal of Pharmacology

Volumn 497, Issue 2, 2004, Pages 187-195

  Ismayilova, Naila ^a   Crossman, Alan ^a   Verkhratsky, Alexei ^a   Brotchie, Jonathan ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Adenosine receptor; Dopamine receptor; l DOPA induced dyskinesia; Locomotion; mGlu5 receptor; Parkinson's disease

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; CHLORO 7,8 DIHYDROXY 3 ALLYL 1 PHENYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPINE HYDROBROMIDE; CYCLOPENTYLADENOSINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; LEVODOPA; METABOTROPIC RECEPTOR ANTAGONIST; RESERPINE; UNCLASSIFIED DRUG; ADENOSINE A1 RECEPTOR; AMINO ACID RECEPTOR AFFECTING AGENT; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GLUR5 KAINATE RECEPTOR; KAINIC ACID RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DYSKINESIA; LOCOMOTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; DOPAMINE AGENTS; EXCITATORY AMINO ACID AGENTS; LOCOMOTION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RECEPTORS, DOPAMINE D1; RECEPTORS, KAINIC ACID; RESERPINE;

EID: 4143121525     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.06.030     Document Type: Article

References (54)

1. B. Alberts, D. Bray, M. Raff, K. Roberts, and J. Watson Cell signalling M. Robertson Molecular biology of the cell 1994 Galand Publishing New York 721 782
2. R.L. Albin, A.B. Young, and J.B. Penney The functional anatomy of basal ganglia disorders Trends Neurosci. 12 1989 366 375
3. G.E. Alexander Basal ganglia-thalamocortical circuits: their role in control of movements J. Clin. Neurophysiol. 11 1994 420 431
4. N.E. Anden Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system Eur. J. Pharmacol. 1 1967 1 5
5. J.J. Anderson, S.P. Rao, B. Rowe, D.R. Giracello, G. Holtz, D.F. Chapman, L. Tehrani, M.J. Bradbury, N.D. Cosford, and M.A. Varney [3H]Methoxymethyl-3- [(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization J. Pharmacol. Exp. Ther. 303 2002 1044 1051
6. R. Basheer, E. Arrigoni, H.S. Thatte, R.W. Greene, I.S. Ambudkar, and R.W. McCarley Adenosine induces inositol 1,4,5-trisphosphate receptor-mediated mobilization of intracellular calcium stores in basal forebrain cholinergic neurons J. Neurosci. 22 2002 7680 7686
7. E. Bezard, J.M. Brotchie, and C.E. Gross Pathophysiology of levodopa-induced dyskinesia: potential for new therapies Nat. Rev., Neurosci. 2 2001 577 588
8. K. Biber, K.N. Klotz, M. Berger, P.J. Gebicke-Harter, and D. van Calker Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression J. Neurosci. 17 1997 4956 4964
9. F. Blandini, G. Nappi, C. Tassorelli, and E. Martignoni Functional changes of the basal ganglia circuitry in Parkinson's disease Prog. Neurobiol. 62 2000 63 88
10. J.M. Brotchie Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease Mov. Disord. 13 1998 871 876
11. R.J. Cormier, S. Mennerick, H. Melbostad, and C.F. Zorumski Basal levels of adenosine modulate mGluR5 on rat hippocampal astrocytes Glia 33 2001 24 35
12. A.R. Crossman Functional anatomy of movement disorders J. Anat. 196 Pt. 4 2000 519 525
13. L.B. Dale, A.V. Babwah, and S.S. Ferguson Mechanisms of metabotropic glutamate receptor desensitization: role in the patterning of effector enzyme activation Neurochem. Int. 41 2002 319 326
14. Z. Diaz-Cabiale, M. Vivo, A. Del Arco, W.T. O'Connor, M.K. Harte, C.E. Muller, E. Martinez, P. Popoli, K. Fuxe, and S. Ferre Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors Neurosci. Lett. 324 2002 154 158
15. R.S. Feldman, J.S. Meyer, and F.Q. Linda Catecholamines R.S. Feldman J.S. Meyer F.Q. Linda Principles of Neuropsychopharmacology 1997 Sinauer Associates Sunderland, MA 277 344
16. S. Fenu, A. Carta, and M. Morelli Modulation of dopamine D1-mediated turning behavior and striatal c-fos expression by the substantia nigra Synapse 19 1995 233 240
17. S. Ferre, K. Fuxe, G. von Euler, B. Johansson, and B.B. Fredholm Adenosineâ€"dopamine interactions in the brain Neuroscience 51 1992 501 512
18. S. Ferre, P. Popoli, L. Gimenez-Llort, U.B. Finnman, E. Martinez, A. Scotti de Carolis, and K. Fuxe Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors NeuroReport 6 1994 73 76
19. S. Ferre, W.T. O'Connor, P. Svenningsson, L. Bjorklund, J. Lindberg, B. Tinner, I. Stromberg, M. Goldstein, S.O. Ogren, U. Ungerstedt, B.B. Fredholm, and K. Fuxe Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms Eur. J. Neurosci. 8 1996 1545 1553
20. S. Ferre, B.B. Fredholm, M. Morelli, P. Popoli, and K. Fuxe Adenosineâ€"dopamine receptorâ€"receptor interactions as an integrative mechanism in the basal ganglia Trends Neurosci. 20 1997 482 487
21. S. Ferre, M. Torvinen, K. Antoniou, E. Irenius, O. Civelli, E. Arenas, B.B. Fredholm, and K. Fuxe Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells J. Biol. Chem. 273 1998 4718 4724
22. S. Ferre, R. Rimondini, P. Popoli, R. Reggio, A. Pezzola, A.C. Hansson, A. Andersson, and K. Fuxe Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour Eur. J. Neurosci. 11 1999 3884 3892
23. S.H. Fox, and J.M. Brotchie 5-HT(2C) receptor antagonists enhance the behavioural response to dopamine D(1) receptor agonists in the 6-hydroxydopamine-lesioned rat Eur. J. Pharmacol. 398 2000 59 64
24. K. Fuxe, S. Ferre, M. Zoli, and L.F. Agnati Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia Brain Res. Brain Res. Rev. 26 1998 258 273
25. K.M. Hemsley, and A.D. Crocker Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra Neuropsychopharmacology 25 2001 514 526
26. K.M. Hemsley, E.J. Farrall, and A.D. Crocker Dopamine receptors in the subthalamic nucleus are involved in the regulation of muscle tone in the rat Neurosci. Lett. 317 2002 123 126
27. R.E. Kingsley Motor system III: the Basal Ganglia P.J. Kelly K.H. Scogna K.M. Ruppert Concise Text of Neuroscience 2000 Lippincott, Williams and Wilkins Philadelphia 285 310
28. K.W. Lange, J. Kornhuber, and P. Riederer Dopamine/glutamate interactions in Parkinson's disease Neurosci. Biobehav. Rev. 21 1997 393 400
29. L. Mao, and J.Q. Wang Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons Brain Res. Mol. Brain Res. 86 2001 125 137
30. M.J. Marino, O. Valenti, and P.J. Conn Glutamate receptors and Parkinson's disease: opportunities for intervention Drugs Aging 20 2003 377 397
31. A.M. Murray, and J.L. Waddington The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction Eur. J. Pharmacol. 160 1989 377 384
32. T. Nakamura, K. Nakamura, N. Lasser-Ross, J.G. Barbara, V.M. Sandler, and W.N. Ross Inositol 1,4,5-trisphosphate (IP3)-mediated Ca2+ release evoked by metabotropic agonists and backpropagating action potentials in hippocampal CA1 pyramidal neurons J. Neurosci. 20 2000 8365 8376
33. J.E. Nash, M.P. Hill, and J.M. Brotchie Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat Exp. Neurol. 155 1999 42 48
34. K.M. O'Boyle, D.E. Gaitanopoulos, M. Brenner, and J.L. Waddington Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor Neuropharmacology 28 1989 401 405
35. M. Okada, K. Mizuno, and S. Kaneko Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum Neurosci. Lett. 212 1996 53 56
36. K. Ossowska The role of excitatory amino acids in experimental models of Parkinson's disease J. Neural Transm., Parkinson's Dis. Dement. Sect. 8 1994 39 71
37. K. Ossowska, J. Konieczny, J. Wardas, K. Golembiowska, S. Wolfarth, and A. Pilc The role of striatal metabotropic glutamate receptors in Parkinson's disease Amino Acids 23 2002 193 198
38. N.K. Parelkar, and J.Q. Wang Preproenkephalin mRNA expression in rat dorsal striatum induced by selective activation of metabotropic glutamate receptor subtype-5 Synapse 47 2003 255 261
39. R.D. Peavy, S.D. Sorensen, and P.J. Conn Differential regulation of metabotropic glutamate receptor 5-mediated phosphoinositide hydrolysis and extracellular signal-regulated kinase responses by protein kinase C in cultured astrocytes J. Neurochem. 83 2002 110 118
40. P. Popoli, A. Pezzola, and A.S. de Carolis Modulation of striatal adenosine A1 and A2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats Eur. J. Pharmacol. 257 1994 21 25
41. P. Popoli, S. Ferre, A. Pezzola, R. Reggio, A. Scotti de Carolis, and K. Fuxe Stimulation of adenosine A1 receptors prevents the EEG arousal due to dopamine D1 receptor activation in rabbits Eur. J. Pharmacol. 305 1996 123 126
42. P. Popoli, L. Gimenez-Llort, A. Pezzola, R. Reggio, E. Martinez, K. Fuxe, and S. Ferre Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents Neurosci. Lett. 218 1996 209 213
43. P. Popoli, R. Reggio, and A. Pezzola Adenosine A1 and A2 receptor agonists significantly prevent the electroencephalographic effects induced by MK-801 in rats Eur. J. Pharmacol. 333 1997 143 146
44. P. Popoli, R. Reggio, A. Pezzola, K. Fuxe, and S. Ferre Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats Neurosci. Lett. 251 1998 201 204
45. P. Popoli, A. Pezzola, M. Torvinen, R. Reggio, A. Pintor, L. Scarchilli, K. Fuxe, and S. Ferre The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors Neuropsychopharmacology 25 2001 505 513
46. R. Rimondini, S. Ferre, L. Gimenez-Llort, S.O. Ogren, and K. Fuxe Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats Eur. J. Pharmacol. 347 1998 153 158
47. C. Romano, M.A. Sesma, C.T. McDonald, K. O'Malley, A.N. Van den Pol, and J.W. Olney Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain J. Comp. Neurol. 355 1995 455 469
48. G. Segovia, F. Mora, A.R. Crossman, and J.M. Brotchie Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease Mov. Disord. 18 2003 138 149
49. M.A. Silverdale, S. McGuire, A. McInnes, A.R. Crossman, and J.M. Brotchie Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease Exp. Neurol. 169 2001 400 406
50. Y. Smith, E. Shink, and M. Sidibe Neuronal circuitry and synaptic connectivity of the basal ganglia Neurosurg. Clin. N. Am. 9 1998 203 222
51. M.S. Starr Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease Synapse 19 1995 264 293
52. S.J. Tallaksen-Greene, K.W. Kaatz, C. Romano, and R.L. Albin Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons Brain Res. 780 1998 210 217
53. C.M. Testa, D.G. Standaert, A.B. Young, and J.B. Penney Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat J. Neurosci. 14 1994 3005 3018
54. C.M. Testa, D.G. Standaert, G.B. Landwehrmeyer, J.B. Penney Jr., and A.B. Young Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons J. Comp. Neurol. 354 1995 241 252